Endo International | ENDP - Passivo Circulante



Passivo Circulante Alterar Data
AbbVie USD 43.29B 3.9B 2025-12
Amarin USD 182.23M 3.71M 2025-09
ANI Pharmaceuticals USD 278.11M 7.56M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Coherus Biosciences USD 140.39M 231.91M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Heron Therapeutics USD 89.71M 168.89M 2025-09
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Ligand Pharmaceuticals USD 37.45M 6.91M 2025-12
Merck USD 28.63B 2.59B 2025-09
Novartis USD 32B 286M 2025-09
Pacira USD 120.59M 13.51M 2025-12
Perrigo USD 1.01B 132.4M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Phibro Animal Health USD 282.37M 12.23M 2025-12
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Takeda JPY 2.61T 470.53B 2025-12
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
Xeris Pharmaceuticals USD 116.2M 21.03M 2025-09
Zoetis USD 2.24B 428M 2025-12